Trial Outcomes & Findings for Neuromodulatory Treatments for Pain Management in TBI (NCT NCT03418129)

NCT ID: NCT03418129

Last Updated: 2023-07-27

Results Overview

Measured by the Defense and Veterans Pain Rating Scale (DVPRS), a graphic tool to facilitate self-reported pain rating using a scale from 0-10, 0 being "no pain" to 10 being "as bad as it could be, nothing else matters."

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

254 participants

Primary outcome timeframe

Baseline and 12 weeks

Results posted on

2023-07-27

Participant Flow

Participant milestones

Participant milestones
Measure
Mobile App Mindfulness
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Mindfulness: Neuromodulatory intervention for pain management
Mobile App Neurofeedback
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Neurofeedback: Neuromodulatory intervention for pain management
Mobile App Relaxation
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Relaxation: Neuromodulatory intervention for pain management
Overall Study
STARTED
84
85
85
Overall Study
COMPLETED
70
59
66
Overall Study
NOT COMPLETED
14
26
19

Reasons for withdrawal

Reasons for withdrawal
Measure
Mobile App Mindfulness
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Mindfulness: Neuromodulatory intervention for pain management
Mobile App Neurofeedback
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Neurofeedback: Neuromodulatory intervention for pain management
Mobile App Relaxation
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Relaxation: Neuromodulatory intervention for pain management
Overall Study
Lost to Follow-up
11
20
15
Overall Study
Withdrawal by Subject
3
6
4

Baseline Characteristics

Neuromodulatory Treatments for Pain Management in TBI

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Mobile App Mindfulness
n=84 Participants
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Mindfulness: Neuromodulatory intervention for pain management
Mobile App Neurofeedback
n=85 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Neurofeedback: Neuromodulatory intervention for pain management
Mobile App Relaxation
n=85 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Relaxation: Neuromodulatory intervention for pain management
Total
n=254 Participants
Total of all reporting groups
Age, Continuous
41.45 years
STANDARD_DEVIATION 8.78 • n=93 Participants
41.99 years
STANDARD_DEVIATION 9.27 • n=4 Participants
40.69 years
STANDARD_DEVIATION 8.63 • n=27 Participants
41.38 years
STANDARD_DEVIATION 8.88 • n=483 Participants
Sex: Female, Male
Female
13 Participants
n=93 Participants
20 Participants
n=4 Participants
17 Participants
n=27 Participants
50 Participants
n=483 Participants
Sex: Female, Male
Male
71 Participants
n=93 Participants
65 Participants
n=4 Participants
68 Participants
n=27 Participants
204 Participants
n=483 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants
n=93 Participants
12 Participants
n=4 Participants
7 Participants
n=27 Participants
25 Participants
n=483 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
70 Participants
n=93 Participants
65 Participants
n=4 Participants
61 Participants
n=27 Participants
196 Participants
n=483 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
8 Participants
n=93 Participants
8 Participants
n=4 Participants
17 Participants
n=27 Participants
33 Participants
n=483 Participants
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants
n=93 Participants
2 Participants
n=4 Participants
5 Participants
n=27 Participants
10 Participants
n=483 Participants
Race (NIH/OMB)
Asian
2 Participants
n=93 Participants
2 Participants
n=4 Participants
0 Participants
n=27 Participants
4 Participants
n=483 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=93 Participants
1 Participants
n=4 Participants
3 Participants
n=27 Participants
5 Participants
n=483 Participants
Race (NIH/OMB)
Black or African American
14 Participants
n=93 Participants
13 Participants
n=4 Participants
13 Participants
n=27 Participants
40 Participants
n=483 Participants
Race (NIH/OMB)
White
63 Participants
n=93 Participants
65 Participants
n=4 Participants
58 Participants
n=27 Participants
186 Participants
n=483 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
0 Participants
n=483 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=93 Participants
2 Participants
n=4 Participants
6 Participants
n=27 Participants
9 Participants
n=483 Participants
Region of Enrollment
United States
84 Participants
n=93 Participants
85 Participants
n=4 Participants
85 Participants
n=27 Participants
254 Participants
n=483 Participants

PRIMARY outcome

Timeframe: Baseline and 12 weeks

Population: Participants who completed the DVPRS at 0 and 12 weeks.

Measured by the Defense and Veterans Pain Rating Scale (DVPRS), a graphic tool to facilitate self-reported pain rating using a scale from 0-10, 0 being "no pain" to 10 being "as bad as it could be, nothing else matters."

Outcome measures

Outcome measures
Measure
Mobile App Mindfulness
n=75 Participants
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Mindfulness: Neuromodulatory intervention for pain management
Mobile App Neurofeedback
n=68 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Neurofeedback: Neuromodulatory intervention for pain management
Mobile App Relaxation
n=76 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Relaxation: Neuromodulatory intervention for pain management
Change in Self-reported Pain Intensity
-1.02 score on a scale
Standard Deviation 1.32
-0.78 score on a scale
Standard Deviation 1.27
-1.03 score on a scale
Standard Deviation 1.36

SECONDARY outcome

Timeframe: 0 and 12 weeks

Population: EEG measurement was discontinued in March 2020 due to the COVID pandemic. Data not collected on 127 participants.

Average FFT (Fast Fourier Transform) Power (alpha 8-12 Hz) measured as sqrt(uV)/Hz.

Outcome measures

Outcome measures
Measure
Mobile App Mindfulness
n=41 Participants
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Mindfulness: Neuromodulatory intervention for pain management
Mobile App Neurofeedback
n=43 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Neurofeedback: Neuromodulatory intervention for pain management
Mobile App Relaxation
n=43 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Relaxation: Neuromodulatory intervention for pain management
Change in EEG Alpha Power
-0.21 sqrt(uV)/Hz
Standard Deviation 0.40
-0.1 sqrt(uV)/Hz
Standard Deviation 0.41
-0.07 sqrt(uV)/Hz
Standard Deviation 0.35

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline and 24 weeks

Population: Participants who completed the DVPRS at baseline, 12 weeks, and 24 weeks.

Measured by the Defense and Veterans Pain Rating Scale (DVPRS), a graphic tool to facilitate self-reported pain rating using a scale from 0-10, 0 being "no pain" to 10 being "as bad as it could be, nothing else matters." This mean difference represents the mean change in pain intensity between 0 and 24 weeks. Please note that the analysis of results utilized a multilevel modeling (MLM) approach of all available data, which involved analyzing pain intensity data collected at 0, 12, and 24 weeks.

Outcome measures

Outcome measures
Measure
Mobile App Mindfulness
n=71 Participants
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Mindfulness: Neuromodulatory intervention for pain management
Mobile App Neurofeedback
n=58 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Neurofeedback: Neuromodulatory intervention for pain management
Mobile App Relaxation
n=63 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Relaxation: Neuromodulatory intervention for pain management
Change in Self-reported Pain Intensity
-1.22 score on a scale
Standard Deviation 1.73
-0.98 score on a scale
Standard Deviation 1.36
-0.86 score on a scale
Standard Deviation 1.56

Adverse Events

Mobile App Mindfulness

Serious events: 5 serious events
Other events: 24 other events
Deaths: 0 deaths

Mobile App Neurofeedback

Serious events: 5 serious events
Other events: 27 other events
Deaths: 0 deaths

Mobile App Relaxation

Serious events: 3 serious events
Other events: 36 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Mobile App Mindfulness
n=84 participants at risk
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Mindfulness: Neuromodulatory intervention for pain management
Mobile App Neurofeedback
n=85 participants at risk
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Neurofeedback: Neuromodulatory intervention for pain management
Mobile App Relaxation
n=85 participants at risk
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Relaxation: Neuromodulatory intervention for pain management
Cardiac disorders
Cardiac Arrest
1.2%
1/84 • 24 weeks
0.00%
0/85 • 24 weeks
0.00%
0/85 • 24 weeks
General disorders
Anxiety
1.2%
1/84 • 24 weeks
0.00%
0/85 • 24 weeks
1.2%
1/85 • 24 weeks
General disorders
Dizziness
1.2%
1/84 • 24 weeks
0.00%
0/85 • 24 weeks
0.00%
0/85 • 24 weeks
General disorders
Headaches
2.4%
2/84 • 24 weeks
3.5%
3/85 • 24 weeks
1.2%
1/85 • 24 weeks
Blood and lymphatic system disorders
Blood Clot
0.00%
0/84 • 24 weeks
1.2%
1/85 • 24 weeks
0.00%
0/85 • 24 weeks
General disorders
Hospitalization
0.00%
0/84 • 24 weeks
1.2%
1/85 • 24 weeks
1.2%
1/85 • 24 weeks
General disorders
Suicidality
0.00%
0/84 • 24 weeks
1.2%
1/85 • 24 weeks
0.00%
0/85 • 24 weeks

Other adverse events

Other adverse events
Measure
Mobile App Mindfulness
n=84 participants at risk
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Mindfulness: Neuromodulatory intervention for pain management
Mobile App Neurofeedback
n=85 participants at risk
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Neurofeedback: Neuromodulatory intervention for pain management
Mobile App Relaxation
n=85 participants at risk
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks. Relaxation: Neuromodulatory intervention for pain management
General disorders
Drowsiness
23.8%
20/84 • 24 weeks
20.0%
17/85 • 24 weeks
18.8%
16/85 • 24 weeks
General disorders
Irritability
2.4%
2/84 • 24 weeks
15.3%
13/85 • 24 weeks
15.3%
13/85 • 24 weeks
General disorders
Suicidal Ideation
2.4%
2/84 • 24 weeks
1.2%
1/85 • 24 weeks
10.6%
9/85 • 24 weeks

Additional Information

Eric Elbogen, Ph.D.

Duke University

Phone: 919-684-9983

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place